2Young RW. Prevention of lung injury in cardiac surgery: a review [J]. J Extra Corpor Technol, 2014, 46(2): 130-141.
3Hu X, Lu Y, Zhang Y, et al. Remote ischemic preconditioning im- proves spatial learning and memory ability after focal cerebral isch- emia-reperfusion in rats [J]. Perfusion, 2013, 28(6): 546-551.
4Fujii Y, Shirai M, Tsuchimochi H, et al. Hyperoxic condition pro- motes an inflammatory response during cardiopulmonary bypass in a rat model [J]. Artif Organs, 2013, 37(12): 1034-1040.
5Chen S, Xu L, Tang J. Association of interleukin 18 gene polymor- phism with susceptibility to the development of acute lung injury af- ter cardiopulmonary bypass surgery [J]. Tissue Antigens, 2010, 76 (3): 245-249.
6Dong LY, Zheng JH, Qiu XX, et al. Ischemic preconditioning reduces deep hypothermic circulatory arrest cardiopulmonary bypass in- duced lung injury [J]. Eur Rev Med Pharmacol Sci, 2013, 17(13): 1789-1799.
7Luo Y, Wang Y, Poynter JA, et at. Pretreating mesenchymal stem- cells with interleukin-1β and transforming growth factor-β syner- gistically increases vascular endothelial growth factor production and improves mesenchymal stein cells-mediated myocardial protec- tion after acute ischemia [J]. Surgerv. 2012. 151(3): 353-363.
8Goebel U, Siepe M, Mecklenburg A, et al. Reduced pulmonary in- flammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation [J]. Eur J Cardiothorac Surg, 2008, 34(6): 1165-1172.
9Disli OM, Sarihan E, Colak MC, et al. Effects of molsidomine against doxorubicin-induced cardiotoxicity in rats [J]. Eur Surg Res, 2013, 51(1-2): 79-90.
